
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Immunol.
Sec. Alloimmunity and Transplantation
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1574324
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background and hypothesis. The presence of donor-specific anti-HLA antibodies before kidney transplantation (preDSA) is associated with decreased graft survival. The hypothesis was investigated that increasing donor kidney age is negatively associated with the impact of preDSA on graft survival.Outcome of kidney transplantation in a single center cohort of 2024 patients transplanted between 2010 and 2020 with a follow-up of at least 3 years was analyzed to assess this relation.. DSA before transplantation were present in 14% of recipients The presence of DSA before transplantationand showed an independent association with graft loss. The preDSA against HLA class I (2%) or class II (7%) had an adjusted hazard ratio (HR) for death censored graft failure of 5.8 (95% CI 4.4-7.7), while the combination (5%) had a HR of 18.6 (95% CI 13.8-25.1). The preDSA associated increase in graft failure was caused primarily by an increase in the incidence of antibody-mediated rejection (ABMR), intragraft thrombosis and primary non-function. These effects were observed more frequently in the deceased donor kidney transplantations compared to living donor kidney transplantations. The incidence of ABMR was not associated with donor kidney age. However, increasing kidney donor donor kidney age significantly aggravated the negative effect of preDSA on graft survival. For instance, recipients of ≥65 years transplanted with a deceased donor kidney of ≥65 years had an uncensored 1-year and 3-year graft survival of 83% and 67% if transplanted without DSA, this decreased to 56% and 35% if transplanted in the presence of DSA. For comparison, recipients of ≥65 years of a deceased donor kidney of <65 years of age had an uncensored 1-year and 3-year graft survival of 92 % and 78% without preDSA, and if transplanted with preDSA this decreased to 77% and 69%.Conclusions. The negative effect of circulating DSA at time of transplantation on both early and late death-censored graft survival is heavily influenced by donor age.
Keywords: Age donor kidney, Antibody-mediated Rejection, donor-specific anti-HLA antibodies, Graft Survival, Kidney Transplantation
Received: 10 Feb 2025; Accepted: 27 Mar 2025.
Copyright: © 2025 Betjes, Kal-Van Gestel, Roelen, Kho, Heidt, De Weerd and Van De Wetering. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Michiel GH Betjes, Erasmus Medical Center, Rotterdam, Netherlands
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.